首页> 美国卫生研究院文献>American Journal of Human Genetics >A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2.
【2h】

A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2.

机译:2型常染色体显性遗传性多囊肾疾病的囊肿生成功能丧失模型。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Autosomal dominant polycystic kidney disease (ADPKD) is genetically heterogeneous, with at least three chromosomal loci (PKD1, PKD2, and PKD3) that account for the disease. Mutations in the PKD2 gene, on the long arm of chromosome 4, are expected to be responsible for approximately 15% of cases of ADPKD. Although ADPKD is a systemic disease, it shows a focal expression, because <1% of nephrons become cystic. A feasible explanation for the focal nature of events in PKD1, proposed on the basis of the two-hit theory, suggests that cystogenesis results from the inactivation of the normal copy of the PKD1 gene by a second somatic mutation. The aim of this study is to demonstrate that somatic mutations are present in renal cysts from a PKD2 kidney. We have studied 30 renal cysts from a patient with PKD2 in which the germline mutation was shown to be a deletion that encompassed most of the disease gene. Loss-of-heterozygosity (LOH) studies showed loss of the wild-type allele in 10% of cysts. Screening of six exons of the gene by SSCP detected eight different somatic mutations, all of them expected to produce truncated proteins. Overall, >/=37% of the cysts studied presented somatic mutations. No LOH for the PKD1 gene or locus D3S1478 were observed in those cysts, which demonstrates that somatic alterations are specific. We have identified second-hit mutations in human PKD2 cysts, which suggests that this mechanism could be a crucial event in the development of cystogenesis in human ADPKD-type 2.
机译:常染色体显性遗传性多囊肾疾病(ADPKD)在遗传上是异质性的,至少有三个染色体位点(PKD1,PKD2和PKD3)引起了该疾病。在第4号染色体长臂上的PKD2基因突变预计将导致约15%的ADPKD病例。尽管ADPKD是一种全身性疾病,但由于不到1%的肾单位变成了囊性的,因此它显示了局部表达。在两次打击理论的基础上,对PKD1中事件的焦点性质进行了可行的解释,表明囊肿形成是由于第二次体细胞突变使PKD1基因的正常拷贝失活所致。这项研究的目的是证明在PKD2肾脏的肾囊肿中存在体细胞突变。我们已经研究了来自PKD2患者的30个肾囊肿,其中种系突变被证明是包含大多数疾病基因的缺失。杂合性缺失(LOH)研究显示10%的囊肿中野生型等位基因缺失。通过SSCP筛选该基因的六个外显子,发现了八个不同的体细胞突变,所有这些突变均预期会产生截短的蛋白质。总的来说,> / = 37%的囊肿表现出体细胞突变。在这些囊肿中未观察到PKD1基因或D3S1478位点的LOH,这表明体细胞改变是特异性的。我们已经确定了人类PKD2囊肿的第二击突变,这表明该机制可能是人类2型ADPKD囊肿发生发展中的关键事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号